OpenSAFELY Vaccine Coverage Report

AstraZeneca / Priority Group 4

Data from combined, up to 2021-03-07.

Vaccinated at 2021-03-07 (%) Vaccinated at 2021-03-07 (n) Population Vaccinated at 2021-02-28 (%) Vaccinated in past week (%)
Overall - 53.6% 2,505,097 4,677,344 51.2% 2.4%
Sex Female 52.8% 1,328,313 2,516,465 50.1% 2.7%
Male 54.5% 1,176,784 2,160,879 52.4% 2.1%
Ethnicity White - British 57.6% 1,470,119 2,551,731 56.0% 1.6%
White - Irish 51.0% 14,280 27,993 49.8% 1.2%
White - Any other White background 40.0% 58,289 145,677 37.0% 3.0%
Mixed - White and Black Caribbean 34.0% 4,011 11,795 29.7% 4.3%
Mixed - White and Black African 33.1% 4,025 12,152 27.2% 5.9%
Mixed - White and Asian 41.9% 3,185 7,609 36.8% 5.1%
Mixed - Any other mixed background 37.2% 5,726 15,386 32.3% 4.9%
Asian or Asian British - Indian 44.6% 54,194 121,583 39.2% 5.4%
Asian or Asian British - Pakistani 36.2% 35,329 97,552 28.8% 7.4%
Asian or Asian British - Bangladeshi 42.0% 20,769 49,469 29.1% 12.8%
Asian or Asian British - Any other Asian background 40.4% 25,956 64,267 34.7% 5.6%
Black or Black British - Caribbean 31.2% 13,342 42,756 27.0% 4.2%
Black or Black British - African 30.8% 31,885 103,684 24.3% 6.4%
Black or Black British - Any other Black background 29.8% 5,614 18,809 24.9% 5.0%
Other ethnic groups - Chinese 42.2% 5,880 13,923 37.6% 4.7%
Other ethnic groups - Any other ethnic group 36.7% 14,364 39,109 31.1% 5.6%
Patients with any other ethnicity code 54.7% 338,905 619,885 52.6% 2.1%
Ethnicity not stated 54.1% 15,435 28,539 51.5% 2.6%
Ethnicity not recorded 54.4% 383,670 705,327 52.3% 2.1%
Ethnicity (broad categories) White 56.6% 1,542,695 2,725,415 55.0% 1.7%
Mixed 36.1% 16,975 46,963 31.1% 5.1%
South Asian 40.9% 136,269 332,892 33.8% 7.2%
Black 30.8% 50,855 165,249 25.1% 5.7%
Other 38.2% 20,258 53,032 32.8% 5.4%
Unknown 54.5% 738,031 1,353,758 52.4% 2.1%
Index of Multiple Deprivation 1 (most deprived) 49.9% 846,517 1,697,661 46.6% 3.3%
2 51.3% 384,545 749,511 48.3% 3.0%
3 55.3% 417,879 755,258 53.4% 1.9%
4 57.4% 420,133 731,542 56.0% 1.4%
5 (least deprived) 59.0% 413,217 700,854 57.9% 1.1%
Unknown 53.6% 22,785 42,497 51.0% 2.6%
Clinical Risk Groups Patients in Any Clinical Risk Group 52.0% 1,560,153 2,999,115 48.7% 3.3%
Patients with Immunosuppression 52.7% 227,304 431,417 51.0% 1.7%
Patients with CKD 56.6% 231,112 408,618 55.3% 1.3%
Patients who have Chronic Respiratory Disease 56.7% 332,759 587,062 55.4% 1.3%
Patients with Diabetes 47.3% 644,420 1,363,726 41.2% 6.0%
Patients with Chronic Liver disease 52.5% 110,684 210,861 49.3% 3.2%
Patients with CNS Disease (including Stroke/TIA) 56.2% 231,168 411,411 54.0% 2.2%
Patients with Chronic heart disease 57.1% 532,525 932,001 55.6% 1.5%
Patients with Asplenia or Dysfunction of the Spleen 50.1% 41,356 82,593 48.7% 1.4%
Patients with Wider Learning Disability 50.6% 28,413 56,203 46.2% 4.3%
Patients with Severe Mental Health 47.9% 37,331 77,938 42.8% 5.1%
Other Groups Patients who are shielding (High Risk from COVID-19) 47.6% 1,081,479 2,273,628 43.1% 4.5%
Patients with Morbid Obesity 49.5% 164,927 332,871 43.9% 5.7%
Patients who are pregnant 18.1% 5,250 28,973 12.1% 6.0%